Concord Wealth Partners Ishares Biotechnology ETF Transaction History
Concord Wealth Partners
- $591 Million
- Q3 2024
A detailed history of Concord Wealth Partners transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Concord Wealth Partners holds 39 shares of IBB stock, worth $5,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 43
9.3%
Holding current value
$5,224
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IBB
# of Institutions
1,011Shares Held
33.6MCall Options Held
4MPut Options Held
6.48M-
Bank Of America Corp Charlotte, NC7.15MShares$958 Million0.09% of portfolio
-
Morgan Stanley New York, NY3.16MShares$423 Million0.03% of portfolio
-
Citigroup Inc1.98MShares$265 Million0.17% of portfolio
-
Royal Bank Of Canada Toronto, A61.47MShares$197 Million0.05% of portfolio
-
Jane Street Group, LLC New York, NY1.44MShares$192 Million0.05% of portfolio